AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
20 registrations across 4 African markets— 18 active
Markets with IRINOTECAN HYDROCHLORIDE TRIHYDRATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Irocan 300 Injection Concentrate for solution for infusion | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jul 2030 |
| Irocan 100 Injection Concentrate for solution for infusion | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jul 2030 |
| IRITERO 40mg/2ml INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| IRITERO 100mg/5ml INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| IRITERO 40mg/2ml INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| IRITERO 100mg/5ml INJECTION | 🇬🇭Ghana | — | active | Jul 2030 |
| Irocan 40 Injection Concentrate for solution for infusion | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Mar 2030 |
| Irocan 500 injection Concentrate for solution for infusion | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Mar 2030 |
| CAROHET 100 mg/5 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| CAROHET 300 mg/15 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| IRITERO 100 mg/5 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| IRITERO 300 mg/5 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| IRITERO 40 mg/2 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| CAROHET 40 mg/2 ml | 🇿🇦South Africa | Hetero Drugs South Africa (Pty) Ltd | active | Jul 2028 |
| IRENAX 100 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Jan 2022 |
| IRENAX 40 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Jan 2022 |
| SANDOZ IRINOTECAN 100 | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| SANDOZ IRINOTECAN 40 | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| IRINOTECAN
HYDROCHLORIDE
TRIHYDRATE PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | AUROBINDOM PHARMA LIMITED | active | — |
| IRINOTECAN
HYDROCHLORIDE
TRIHYDRATE PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | AUROBINDOM PHARMA LIMITED | active | — |
IRINOTECAN HYDROCHLORIDE TRIHYDRATE in Africa — Regulatory Overview
IRINOTECAN HYDROCHLORIDE TRIHYDRATE is registered across 4 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Zambia, Uganda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 20 registrations, 18 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.